Guidelines

P04 DIFFERENCES IN FVIII MEASUREMENTS OF PLASMA SPIKED WITH AFSTYLA® GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD

November 2018
P05 DIFFERENCES IN ACTIVITY OF PLASMA SPIKED WITH IDELVION® GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD

November 2018
P06 EVALUATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION USING A NEW SEMI-AUTOMATED VON WILLEBRAND MULTIMERIC ASSAY, HYDRAGEL VW MULTIMER (SEBIA)

November 2018
P07 EVALUATION OF AN AUTOMATED VON WILLEBRAND FACTOR COLLAGEN BINDING ASSAY, HEMOSIL® ACUSTAR® VWF:CB

November 2018
P08 RESOLVING DOAC INTERFERENCE ON APTT, PT AND LUPUS ANTICOAGULANT TESTING BY THE USE OF ACTIVATED CARBON

November 2018
P09 COMPARISON OF THE EFFECT OF MANUAL SAMPLE TRANSPORT AND TWO DIFFERENT PNEUMATIC TRANSPORTATION SYSTEMS ON COAGULATION ASSAYS

November 2018
P10 METHOD VALIDATION OF THE NEW STAGO PT REAGENT STANEOPTIMAL FOR PT/INR MEASUREMENT

November 2018
P11 EFFECT OF UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ON THE MEASUREMENT OF PT WITH TWO STAGO PT REAGENTS

November 2018
P12 SENSITIVITY OF THE NEW STAGO PT STA-NEOPTIMAL REAGENT FOR FACTOR DEFICIENCY ON STAGO STA-R EVOLUTION

November 2018
P13 THE VALUE OF LABORATORY SCREENING VS. CLINICAL JUDGMENT IN HIT DIAGNOSIS: EXPERIENCES IN THREE BELGIAN HOSPITALS

November 2018

Top